Patient Guide: A Study to Compare the Efficacy and Safety of Entrectinib and Crizotinib in Participants With Advanced or Metastatic ROS1 Non-small Cell Lung Cancer (NSCLC) With and Without Central Nervous System (CNS) Metastases

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 91 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04603807
Status: 🟢 Enrolling Now
Condition: Carcinoma, Non-Small-Cell Lung
Phase: PHASE3

Where You Can Participate

This study is available at 91 locations across the country.

Top locations include:
  • • Salvador, Bahia
  • • Fortaleza, Ceará
  • • Brasilia, Distrito Federal
  • • And 88 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Compare the Efficacy and Safety of Entrectinib and Crizotinib in Participants With Advanced or Metastatic ROS1 Non-small Cell Lung Cancer (NSCLC) With and Without Central Nervous System (CNS) Metastases - Join Clinical Trial NCTNCT04603807

How to Join This Clinical Trial - NCTNCT04603807

Learn how to participate in this PHASE3 trial studying an investigational therapy for Carcinoma, Non-Small-Cell Lung. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Carcinoma, Non-Small-Cell Lung. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Carcinoma, Non-Small-Cell Lung
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT04603807 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 91 locations. Find a study site near you:

Clinical Research Site

Salvador, Bahia 41253-190 - Brazil

Status: RECRUITING

Clinical Research Site

Fortaleza, Ceará 60130-241 - Brazil

Status: RECRUITING

Clinical Research Site

Brasilia, Distrito Federal 70390-140 - Brazil

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

Belo Horizonte, Minas Gerais 30360-680 - Brazil

Status: WITHDRAWN

Clinical Research Site

Ijui, Rio Grande Do Sul 98700-000 - Brazil

Status: WITHDRAWN

Clinical Research Site

Florianopolis, Santa Catarina 88020-210 - Brazil

Status: RECRUITING

Clinical Research Site

Barretos, São Paulo 14784-400 - Brazil

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

Sao Paulo, São Paulo 01246-000 - Brazil

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

Rio de Janeiro, 22250-905 - Brazil

Status: COMPLETED

Clinical Research Site

Beijing, 100730 - China

Status: WITHDRAWN

And 81 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Carcinoma, Non-Small-Cell Lung:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships